What is the recommended number of doses of meningococcal B (MenB) vaccine for an 18-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Meningococcal B Vaccine Dosing for 18-Year-Olds

For an 18-year-old, the recommended dosing schedule for meningococcal B (MenB) vaccine is either a 2-dose series of MenB-4C (Bexsero) at least 1 month apart or a 2-dose series of MenB-FHbp (Trumenba) at 0 and 6 months. 1, 2, 3

Vaccine Options and Dosing Schedules

There are two MenB vaccines available, and the dosing schedule depends on which product is used:

  1. MenB-4C (Bexsero):

    • 2-dose series with doses administered at least 1 month apart 3, 4
  2. MenB-FHbp (Trumenba):

    • For healthy adolescents (standard schedule): 2 doses administered at 0 and 6 months
    • Important note: If the second dose is administered earlier than 6 months after the first dose, a third dose should be administered at least 4 months after the second dose 5, 3

Risk-Based Considerations

The dosing schedule may differ for individuals at increased risk for meningococcal disease:

  • For high-risk individuals (those with persistent complement component deficiencies, anatomical or functional asplenia, microbiologists routinely exposed to N. meningitidis, or during outbreaks):
    • MenB-FHbp: 3-dose series (0,1-2, and 6 months)
    • MenB-4C: 2-dose series (≥1 month apart) 5, 6, 3

Important Clinical Considerations

  • The two MenB vaccines are not interchangeable - the same product must be used for all doses in a series 1, 5
  • MenB vaccines can be administered concomitantly with MenACWY vaccines, but at different anatomical sites 1
  • The preferred age range for MenB vaccination in healthy adolescents is 16-23 years, with optimal timing at 16-18 years 3
  • For first-year college students aged ≤21 years living in residence halls, MenB vaccination should be considered based on shared clinical decision-making 1, 3

Antibody Persistence

Studies show that protective antibody levels persist after vaccination:

  • After two doses of MenB-4C, 77-94% of subjects maintained protective antibody titers 18-24 months post-vaccination 7
  • For MenB-FHbp, protective antibody titers initially decline but remain stable through 48 months post-vaccination 8

Pitfalls to Avoid

  1. Mixing vaccine products: Never interchange MenB-4C and MenB-FHbp within a vaccination series
  2. Incorrect intervals: If using MenB-FHbp and the second dose is given earlier than 6 months after the first dose, a third dose is required
  3. Confusing with MenACWY: MenB vaccines specifically target serogroup B and are different from MenACWY vaccines that target serogroups A, C, W, and Y
  4. Missing booster doses: For high-risk individuals who remain at increased risk, follow the specific booster recommendations

By following these evidence-based recommendations, clinicians can ensure optimal protection against meningococcal serogroup B disease in 18-year-old patients.

Related Questions

What should be done for a patient who received an expired meningococcal B vaccine (MenB), specifically Bexsero (multicomponent meningococcal B vaccine) or Trumenba (meningococcal group B vaccine), that was 6 days past its expiration date?
What are the recommended dosing schedules for the meningococcal B vaccine (Bexsero) for infants, children, adolescents, adults, and immunocompromised patients?
What is the recommended dosing schedule and frequency for the Bexsero (meningococcal B) vaccine in children in Australia, including age brackets, number of doses, and common side effects?
What is the recommended interval between the first and second doses of Bexsero (meningococcal group B vaccine) for a 2‑year‑old child?
Can a 19‑year‑old who received the first dose of Bexsero (meningococcal group B vaccine) three years ago receive a catch‑up second dose today?
What is the significance of an afferent pupillary defect (APD) of the right pupil?
Can anemia (Hemoglobin level of 9.9 g/dL) cause mild tremor of both hands in a 15-year-old female child?
How long can Xeroform (petrolatum gauze) stay on a wound?
How to manage afferent pupillary defect (APD) suspected to be caused by a vitamin deficiency, specifically vitamin A or vitamin B12 deficiency?
What is the treatment for an elderly patient with abdominal colic, distention, absolute constipation, vomiting, pallor, and a palpable lower abdominal mass?
What is the next step in management for a patient with a normal fecal calprotectin level and persistent gastrointestinal symptoms?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.